Medica Venture Partners is a private equity general partner firm headquartered in Herzliya, Israel.
Regentis Biomaterials, a developer of cartilage repair solutions, closed a $15m Series D funding from SCP Vitalife Partners and others.
VC-backed biopharmaceutical company GlobeImmune has withdrawn its IPO plans due to poor market conditions.
Medica Venture Partners and SCPVitalife, among others, participated in a $10m funding round in Regentis Biomaterials Ltd.
Read more news concerning Medica Venture Partners
A sampling of Medica Venture Partners portfolio companies:
View all of the investments in their portfolio
Registration is fast, free and easy
Already a member?